Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Publisher' newest research report, the “Artificial Heart Lung Machines Industry Forecast” looks at past sales and reviews total world Artificial Heart Lung Machines sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Heart Lung Machines sales for 2023 through 2029. With Artificial Heart Lung Machines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Heart Lung Machines industry.
This Insight Report provides a comprehensive analysis of the global Artificial Heart Lung Machines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Heart Lung Machines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Heart Lung Machines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Heart Lung Machines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Heart Lung Machines.
The global Artificial Heart Lung Machines market size is projected to grow from US$ 272 million in 2022 to US$ 359 million in 2029; it is expected to grow at a CAGR of 359 from 2023 to 2029.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart Lung Machines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Single Roller Pump HLM
Double Roller Pump HLM
Segmentation by application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Heart Lung Machines market?
What factors are driving Artificial Heart Lung Machines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Heart Lung Machines market opportunities vary by end market size?
How does Artificial Heart Lung Machines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Heart Lung Machines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artificial Heart Lung Machines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artificial Heart Lung Machines by Country/Region, 2018, 2022 & 2029
2.2 Artificial Heart Lung Machines Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.3 Artificial Heart Lung Machines Sales by Type
2.3.1 Global Artificial Heart Lung Machines Sales Market Share by Type (2018-2023)
2.3.2 Global Artificial Heart Lung Machines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artificial Heart Lung Machines Sale Price by Type (2018-2023)
2.4 Artificial Heart Lung Machines Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Transplant Operation
2.4.3 Acute Respiratory Failure Treatment
2.4.4 Others
2.5 Artificial Heart Lung Machines Sales by Application
2.5.1 Global Artificial Heart Lung Machines Sale Market Share by Application (2018-2023)
2.5.2 Global Artificial Heart Lung Machines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artificial Heart Lung Machines Sale Price by Application (2018-2023)
3 Global Artificial Heart Lung Machines by Company
3.1 Global Artificial Heart Lung Machines Breakdown Data by Company
3.1.1 Global Artificial Heart Lung Machines Annual Sales by Company (2018-2023)
3.1.2 Global Artificial Heart Lung Machines Sales Market Share by Company (2018-2023)
3.2 Global Artificial Heart Lung Machines Annual Revenue by Company (2018-2023)
3.2.1 Global Artificial Heart Lung Machines Revenue by Company (2018-2023)
3.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Company (2018-2023)
3.3 Global Artificial Heart Lung Machines Sale Price by Company
3.4 Key Manufacturers Artificial Heart Lung Machines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Heart Lung Machines Product Location Distribution
3.4.2 Players Artificial Heart Lung Machines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artificial Heart Lung Machines by Geographic Region
4.1 World Historic Artificial Heart Lung Machines Market Size by Geographic Region (2018-2023)
4.1.1 Global Artificial Heart Lung Machines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artificial Heart Lung Machines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artificial Heart Lung Machines Market Size by Country/Region (2018-2023)
4.2.1 Global Artificial Heart Lung Machines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artificial Heart Lung Machines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artificial Heart Lung Machines Sales Growth
4.4 APAC Artificial Heart Lung Machines Sales Growth
4.5 Europe Artificial Heart Lung Machines Sales Growth
4.6 Middle East & Africa Artificial Heart Lung Machines Sales Growth
5 Americas
5.1 Americas Artificial Heart Lung Machines Sales by Country
5.1.1 Americas Artificial Heart Lung Machines Sales by Country (2018-2023)
5.1.2 Americas Artificial Heart Lung Machines Revenue by Country (2018-2023)
5.2 Americas Artificial Heart Lung Machines Sales by Type
5.3 Americas Artificial Heart Lung Machines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Heart Lung Machines Sales by Region
6.1.1 APAC Artificial Heart Lung Machines Sales by Region (2018-2023)
6.1.2 APAC Artificial Heart Lung Machines Revenue by Region (2018-2023)
6.2 APAC Artificial Heart Lung Machines Sales by Type
6.3 APAC Artificial Heart Lung Machines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artificial Heart Lung Machines by Country
7.1.1 Europe Artificial Heart Lung Machines Sales by Country (2018-2023)
7.1.2 Europe Artificial Heart Lung Machines Revenue by Country (2018-2023)
7.2 Europe Artificial Heart Lung Machines Sales by Type
7.3 Europe Artificial Heart Lung Machines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Heart Lung Machines by Country
8.1.1 Middle East & Africa Artificial Heart Lung Machines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artificial Heart Lung Machines Revenue by Country (2018-2023)
8.2 Middle East & Africa Artificial Heart Lung Machines Sales by Type
8.3 Middle East & Africa Artificial Heart Lung Machines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines
10.3 Manufacturing Process Analysis of Artificial Heart Lung Machines
10.4 Industry Chain Structure of Artificial Heart Lung Machines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Heart Lung Machines Distributors
11.3 Artificial Heart Lung Machines Customer
12 World Forecast Review for Artificial Heart Lung Machines by Geographic Region
12.1 Global Artificial Heart Lung Machines Market Size Forecast by Region
12.1.1 Global Artificial Heart Lung Machines Forecast by Region (2024-2029)
12.1.2 Global Artificial Heart Lung Machines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Heart Lung Machines Forecast by Type
12.7 Global Artificial Heart Lung Machines Forecast by Application
13 Key Players Analysis
13.1 LivaNova (Sorin)
13.1.1 LivaNova (Sorin) Company Information
13.1.2 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolios and Specifications
13.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 LivaNova (Sorin) Main Business Overview
13.1.5 LivaNova (Sorin) Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Artificial Heart Lung Machines Product Portfolios and Specifications
13.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo CV Group
13.4.1 Terumo CV Group Company Information
13.4.2 Terumo CV Group Artificial Heart Lung Machines Product Portfolios and Specifications
13.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Terumo CV Group Main Business Overview
13.4.5 Terumo CV Group Latest Developments
13.5 Braile Biomedica
13.5.1 Braile Biomedica Company Information
13.5.2 Braile Biomedica Artificial Heart Lung Machines Product Portfolios and Specifications
13.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Braile Biomedica Main Business Overview
13.5.5 Braile Biomedica Latest Developments
13.6 Tianjin Medical
13.6.1 Tianjin Medical Company Information
13.6.2 Tianjin Medical Artificial Heart Lung Machines Product Portfolios and Specifications
13.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tianjin Medical Main Business Overview
13.6.5 Tianjin Medical Latest Developments
14 Research Findings and Conclusion
*If Applicable.